We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
New Antithrombotic Drugs in Acute Coronary Syndrome.
- Authors
Zwart, Bastiaan; Parker, William A. E.; Storey, Robert F.
- Abstract
In recent years, much progress has been made in the field of antithrombotic drugs in acute coronary syndrome (ACS) treatment, as reflected by the introduction of the more potent P2Y12-inhibitors prasugrel and ticagrelor, and novel forms of concomitant anticoagulation, such as fondaparinux and bivalirudin. However, despite substantial improvements in contemporary ACS treatment, there remains residual ischemic risk in this group and hence the need for even more effective antithrombotic drugs, while balancing antithrombotic efficacy against bleeding risk. This review discusses recently introduced and currently developed antiplatelet and anticoagulant drugs in ACS treatment.
- Subjects
ACUTE coronary syndrome; PLATELET aggregation inhibitors; DRUGS
- Publication
Journal of Clinical Medicine, 2020, Vol 9, Issue 7, p2059
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm9072059